6Ruijter E,Van De Kaa C,Miller G,et al.Molecular genetics and epidemiology of prostate carcinoma [J].Endocr Rev,1999,20:22-45.
7Miller G.Vitamin D and prostate cancer:biologic interactions a nd clinical potentials [J].Cancer Met Rev,1999,17:353-360.
8Blutt S,Weigel N.Vitamin D and prostate cancer [J].Proc Soc Exp Biol Med,1999,211:89-98.
9Taylor J A,Hirvone A,Watson M,et al.Association of prostate ca ncer with vitamin D receptor gene polymorphism [J].Cancer Res,1996,56:4108-41 10.
10Ingles S A,Ress R K,Yu M C,et al.Association of prostate cance r risk with genetic polymorphisms in vitamin D receptor and androgen receptor [ J].J Natl Cancer Inst,1997,89:166-170.
3Whittemore AS, Kolonel LN, Wu AH, et al. Prostate cancer in relation to diet, physical activity, and body size in blacks, whites, Asians in the United States and Canada. J Natl Cancer Inst, 1995, 87 : 652-661.
4Jain MG, Hislop GT, Howe GR, et al. Plant foods, antioxidants, and prostate cancer risk: findings from case-control studies in Canada. Nutr Cancer, 1999,34 : 173-184.
5Sanderson M, Coker' ALl Logan P, et al. Lifestyle and prostate cancer among older Mrican-American and Caucasian men in South Carolina. Cancer Causes Control ,2004,15: 647-655.
6Johns LE, Houlston RS. A systematic review and meta-analysis of familial prostate cancer risk ( Review ) . BJU Int, 2003, 91 : 789-794.
7Haiman CA, Stampfer MJ, Giovannueei E, et al. The relationship between a polymorphism in CYP17 with plasma hormone levels and prostate cancer. Cancer Epidemiol Biomarkers Prey ,2001,10: 743-748.
8Giovannucci E,Ascherio A,Rimm E B,et al.A prospective cohort study of vasectomy and prostate cancer in US men[J].JAMA,1993,269(7):873-877.
9Garraway W M,Collins G N,Lee R J.High prevalence of benign prostatic hyperplasia in the community[J].Lancet,1991,338 (8765):469 -471.
10Johns L E,Houlston R S.A systematic review and metaanalysis of familial prostate cancer risk[J].BJU Int,2003,91 (9):789-794.
